Company: BUDZ
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001096906-25-000350
Chunk: 384

Company: WEED, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 3
Chunk 384
---
informatics data systems available.
No work is being conducted now until further funds are available.

On May 2, 2022, the Company acquired Hempirical Genetics,
LLC, a Arizona company.

The accompanying financial statements have been prepared
in conformity with accounting principles generally accepted in the United States of America. These statements reflect all adjustments,
consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information
contained therein.

The Company has a calendar year end for reporting
purposes.

Basis of Presentation:

The accompanying consolidated balance sheet at December
31, 2024, has been derived from audited consolidated financial statements and the unaudited condensed consolidated financial statements
as of December 31, 2024 and 2023 ( the “financial statements”), have been prepared in accordance with accounting principles
generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to
Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for
complete financial statements and should be read in conjunction with the audited consolidated financial statements and related footnotes.
It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made
which are necessary for a fair financial statements presentation. The consolidated financial statements include all material adjustments
(consisting of normal recurring accruals) necessary to make the consolidated financial statements not misleading as required by Regulation
S-X, Rule 10-01. Interim result are not necessarily indicative of results for a full year.

Principles of Consolidation

The accompanying consolidated financial statements
include the accounts of the following entities, all of which are under common control and ownership:

    Schedule of entities under common control and ownership

    State of

    Abbreviated
  
    Name of Entity
     
    Incorporation
     
    Relationship (1&3)
     
    Reference
  
    WEED, Inc.
     
    Nevada
     
    Parent
     
    WEED
  
    Sangre AT, LLC (2)
     
    Wyoming
     
    Subsidiary
     
    Sangre
  
    Hempirical Genetics, LLC (3)
     
    Arizona
     
    Subsidiary
     
    Hempirical Generics

(1) Sangre is a wholly-owned subsidiary of WEED, Inc.

(2)